Global Anti-snoring Treatment Market size will grow considerably through 2032. The increasing geriatric population base and its greater susceptibility to sleeping disorders has bolstered the need for anti-snoring treatment globally. Moreover, the industry growth can also be attributed to growing advancements in anti-snoring devices. Technological breakthroughs in the field have led to the development of smart anti-snoring devices that integrate sensors and algorithms to monitor and analyze snoring patterns. These devices provide real-time feedback, track sleep data, and can be connected to smartphone apps for personalized monitoring and treatment optimization. Furthermore, many industry leaders are focusing on constant product innovations to sustain their leadership. Citing an instance, in December 2022, a leading provider of medical devices announced the launch of the mWearTM system, a new wearable patient monitoring solution helping monitor patient conditions to provide advanced patient-focused care.The overall anti-snoring treatment market is divided based on device, distribution channel, and region. The overall anti-snoring treatment market is divided based on device, distribution channel, and region. The nasal device market share will grow at more than 7.5% CAGR from 2023 to 2032. The ease of use and portability of nasal devices will support segment growth. Consistent advancements in nasal device technology have led to the development of app-connected nasal devices. These can be connected to a smartphone app that provides real-time feedback, monitoring, and personalized settings. Users can track their snoring patterns, adjust device settings, and gather data to understand their sleep quality better. In terms of distribution channel, anti-snoring treatment market size from the clinics segment was worth more than USD 280 million in 2022. High availability of skilled healthcare professionals in clinics has increased their popularity among patients. Additionally, these facilities often provide access to a wide range of advanced treatment options beyond over-the-counter remedies. These may include oral appliances, continuous positive airway pressure (CPAP) therapy, surgical interventions, or other specialized therapies. They also provide awareness and support to patients, helping them understand the causes and consequences of snoring and the available treatment options. Asia Pacific anti-snoring treatment industry will garner huge gains through 2032. Rising prevalence of sleep disorders has increased the need for anti-snoring treatment in the region. The region has an expansive aging population base. Moreover, regional growth can also be attributed to the flourishing healthcare sector and favorable regulatory framework for medical devices for enhanced patient care. According to Invest India, the country’s Medtech industry will hit over USD 50 billion by 2030.
Chapter 1 Methodology & Scope
1.1 Methodology
1.2 Market scope & definitions
1.3 Base estimates & working
1.3.1 North America
1.3.2 Europe
1.3.3 Asia Pacific
1.3.4 Latin America
1.3.5 MEA
1.4 Forecast calculations
1.5 Data validation
1.6 COVID-19 impact analysis at global level
1.7 Data sources
1.7.1 Primary
1.7.2 Secondary
1.7.2.1 Paid sources
1.7.2.2 Unpaid sources
Chapter 2 Executive Summary
2.1 Anti-snoring treatment industry 360 degree synopsis, 2018 - 2032
2.1.1 Business trends (USD Miliion & Units)
2.1.2 Device trends (USD Miliion & Units)
2.1.3 Distribution channel trends (USD Miliion & Units)
2.1.4 Regional trends (USD Miliion & Units)
Chapter 3 Anti-snoring Treatment Industry Insights
3.1 Industry landscape, 2018 – 2032
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Rising geriatric and obese people
3.2.1.2 Growing cigarette and alcohol consumption
3.2.1.3 Technological advancement in anti-snoring devices
3.2.1.4 Increasing prevalence of sleep disorder
3.2.2 Industry pitfalls & challenges
3.2.2.1 High cost of devices
3.2.2.2 Lack of reimbursement policies
3.3 Growth potential analysis
3.3.1 By device
3.3.2 By distribution channel
3.4 COVID-19 impact analysis
3.5 Regulatory landscape
3.6 Porter’s analysis
3.7 PESTEL analysis
Chapter 4 Competitive Landscape, 2021
4.1 Introduction
4.2 Competitive dashboard, 2021
4.3 Company matrix analysis, 2021
4.4 Competitive analysis of major market players
4.5 Competitive positioning matrix
4.6 Strategic outlook matrix
Chapter 5 Anti-snoring Treatment Market, By Device
5.1 Key segment trends
5.2 Mandible advancement devices
5.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.2.2 Market estimates and forecast, 2018 - 2032 (Units)
5.3 Tongue stabilizing devices
5.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.3.2 Market estimates and forecast, 2018 - 2032 (Units)
5.4 Nasal devices
5.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.4.2 Market estimates and forecast, 2018 - 2032 (Units)
5.5 Continuous positive airway pressure devices
5.5.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.5.2 Market estimates and forecast, 2018 - 2032 (Units)
5.6 Chin straps
5.6.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.6.2 Market estimates and forecast, 2018 - 2032 (Units)
5.7 Others
5.7.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.7.2 Market estimates and forecast, 2018 - 2032 (Units)
Chapter 6 Anti-snoring Treatment Market, By Distribution channel
6.1 Key segment trends
6.2 Hospitals
6.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.2.2 Market estimates and forecast, 2018 - 2032 (Units)
6.3 Clinics
6.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.3.2 Market estimates and forecast, 2018 - 2032 (Units)
6.4 Retail pharmacies
6.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.4.2 Market estimates and forecast, 2018 - 2032 (Units)
6.5 E-commerce
6.5.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.5.2 Market estimates and forecast, 2018 - 2032 (Units)
6.6 Others
6.6.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.6.2 Market estimates and forecast, 2018 - 2032 (Units)
Chapter 7 Anti-snoring Treatment Market Market, By Region
7.1 Key regional trends
7.2 North America
7.2.1 U.S.
7.2.2 Canada
7.3 Europe
7.3.1 Germany
7.3.2 UK
7.3.3 France
7.3.4 Spain
7.3.5 Italy
7.3.6 Russia
7.3.7 Poland
7.3.8 Switzerland
7.3.9 The Netherlands
7.4 Asia Pacific
7.4.1 China
7.4.2 India
7.4.3 Japan
7.4.4 Australia
7.4.5 South Korea
7.4.6 Thailand
7.4.7 Indonesia
7.5 Latin America
7.5.1 Brazil
7.5.2 Mexico
7.5.3 Argentina
7.5.4 Colombia
7.5.5 Chile
7.6 Middle East & Africa
7.6.1 Saudi Arabia
7.6.2 South Africa
7.6.3 UAE
7.6.4 Israel
Chapter 8 Company Profiles
8.1 Apnea Science
8.2 SomnoMed
8.3 Koninklijke Philips
8.4 The Pure Sleep Company
8.5 Airway Management Inc
8.6 Tomed GmBH
8.7 Meditas
8.8 GlaxoSmithKline Plc
8.9 Fisher & Paykel Healthcare
8.10 ResMed
8.11 Theravent (Foundation Consumer Healthcare)
8.12 The Pure Sleep Co (Sleep Science Partners, Inc)
8.13 Vyaire Medical
Data Tables
TABLE 1. Product mapping
TABLE 2. Market revenue, by device (2022)
TABLE 3. Market revenue, by distribution channel (2022)